SCHEMBL16397724

SCHEMBL16397724

O=C(O)c1c(N(Cc2ccccc2)Cc2ccccc2)c2ccccc2oc1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 2/20 0.46
▸ CA12 O43570 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ CSNK2A2 P19784 1/20 0.43
▸ PTGS1 P23219 1/20 0.43
▸ CSNK2B P67870 1/20 0.43
▸ CSNK2A1 P68400 1/20 0.43
▸ CSNK2A3 Q8NEV1 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ CNR2 P34972 1/20 0.42
▸ GAA P10253 2/20 0.41
▸ LMNA P02545 4/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ HPGD P15428 2/20 0.40
▸ SLC16A3 O15427 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957427 0.84 ALDH1A1 (0.49) NQO1CA12CA9KDM4EALDH1A1
SCHEMBL3170077 0.80 GAA (0.60) NQO1CA12CA9KDM4EUSP2
SCHEMBL31222315 0.80 GAA (0.60) NQO1CA12CA9KDM4EUSP2
Coumarin SCHEMBL2477007 0.75 CA12 (0.46) CA12CA9KDM4EALDH1A1GAA
SCHEMBL7753264 0.75 CA12 (0.57) NQO1CA12CA9KDM4EUSP2
SCHEMBL1883659 0.74 ALDH1A1 (0.50) NQO1CA12CA9KDM4EALDH1A1
SCHEMBL31344359 0.74 MAOB (0.50) NQO1CA12CA9ALDH1A1GAA
SCHEMBL29623856 0.73 CA12 (0.60) CA12CA9KDM4EALDH1A1GAA
SCHEMBL1648027 0.72 CA12 (0.73) NQO1CA12CA9KDM4EALDH1A1
SCHEMBL29901650 0.72 CA12 (0.73) NQO1CA12CA9KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3004073-A1 3-CARBOXY SUBSTITUTED COUMARIN DERIVATIVES WITH A POTENTIAL UTILITY FOR THE TREATMENT OF CANCER DISEASES Université catholique de Louvain (BE) 2016-04-13 — — EP disclosed
WO-2014195507-A1 3-CARBOXY SUBSTITUTED COUMARIN DERIVATIVES WITH A POTENTIAL UTILITY FOR THE TREATMENT OF CANCER DISEASES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2014-12-11 — — WO disclosed
Send feedback